LUCEMYRA Drug Patent Profile
✉ Email this page to a colleague
When do Lucemyra patents expire, and what generic alternatives are available?
Lucemyra is a drug marketed by Uswm and is included in one NDA.
The generic ingredient in LUCEMYRA is lofexidine hydrochloride. One supplier is listed for this compound. Additional details are available on the lofexidine hydrochloride profile page.
Summary for LUCEMYRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 8 |
Patent Applications: | 218 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LUCEMYRA |
What excipients (inactive ingredients) are in LUCEMYRA? | LUCEMYRA excipients list |
DailyMed Link: | LUCEMYRA at DailyMed |
Recent Clinical Trials for LUCEMYRA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
New York State Psychiatric Institute | Phase 1/Phase 2 |
Clinilabs, Inc. | Phase 1/Phase 2 |
Yale University | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for LUCEMYRA
US Patents and Regulatory Information for LUCEMYRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uswm | LUCEMYRA | lofexidine hydrochloride | TABLET;ORAL | 209229-001 | May 16, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |